Table 3.
Results of univariable and multivariable analysis for all-cause 30-day mortality
| Variable | Univariable | Multivariable | ||||
| P value | HR | 95% CI | P value | HR | 95% CI | |
| Body mass index, kg/m2 | <0.000 | 0.78 | 0.68 to 0.90 | <0.000 | 0.73 | 0.61 to 0.87 |
| Heart failure | 0.083 | 2.78 | 0.90 to 5.80 | 0.03 | 2.95 | 1.11 to 7.78 |
| Access | 0.004 | 0.017 | ||||
| Transfemoral | Ref | Ref | ||||
| Transaortic | 0.905 | 0.88 | 0.10 to 7.51 | 0.614 | 0.57 | 0.06 to 5.14 |
| Transapical | 0.011 | 4.98 | 1.78 to 13.99 | 0.015 | 3.8 | 1.29 to 11.16 |
| SPAP, mm Hg | 0.053 | 0.004 | ||||
| <30 | Ref | Ref | ||||
| 30–60 | 0.737 | 1.22 | 0.38 to 3.89 | 0.688 | 1.28 | 0.39 to 4.14 |
| >60 | 0.038 | 4.03 | 1.08 to 14.99 | 0.004 | 7.77 | 1.90 to 31.28 |
| Peripheral artery disease | 0.002 | 5.16 | 1.86 to 14.34 | 0.002 | 5.95 | 1.97 to 17.99 |
| MR moderate to severe | 0.091 | 2.24 | 0.88 to 5.68 | NS | – | – |
| COPD | 0.065 | 1.40 | 1.01 to 7.79 | NS | – | – |
| Previous cardiac surgery | 0.101 | 0.43 | 0.15 to 1.18 | NS | – | – |
| eGFR ml/min/1.73 m2 | 0.055 | 0.98 | 0.96 to 1.00 | NS | – | – |
| Porcelain aorta | 0.048 | 2.81 | 1.01 to 7.79 | NS | – | – |
COPD, chronic obstructive pulmonary disease;MR, mitral regurgitation;NS, non-significant;SPAP, systolic pulmonary arterial pressure; eGFR, estimated glomerular filtration rate.